Make a Living ClubMake a Living Club
  • Home
  • News
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • More
    • Economy
    • Politics
    • Real Estate
Trending Now

Bear Market? Prepare Now With These 5 Best Stocks

December 11, 2025

TWFG: A Growing Insurance ‘Middle Man’ (NASDAQ:TWFG)

December 10, 2025

Trump’s immigration data dragnet

December 10, 2025

Shinhan Financial: Watch Out For Positive Surprises (NYSE:SHG)

December 9, 2025

Asante Gold: Growth In Medium-Sized Gold Production, But With Relevant Risk

December 8, 2025

The power crunch threatening America’s AI ambitions

December 8, 2025
Facebook Twitter Instagram
  • Privacy
  • Terms
  • Press
  • Advertise
  • Contact
Facebook Twitter Instagram
Make a Living ClubMake a Living Club
  • Home
  • News
  • Business
  • Finance
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • More
    • Economy
    • Politics
    • Real Estate
Sign Up for News & Alerts
Make a Living ClubMake a Living Club
Home » Rite Aid files for Chapter 11 amid declining sales and opioid crisis lawsuits
Stocks

Rite Aid files for Chapter 11 amid declining sales and opioid crisis lawsuits

Press RoomBy Press RoomOctober 17, 2023
Facebook Twitter Pinterest LinkedIn WhatsApp Email

© Reuters.

Rite Aid (NYSE:), once the largest pharmacy chain in the US, has filed for Chapter 11 bankruptcy protection to a mounting debt crisis, declining sales, and ongoing lawsuits related to its alleged role in the opioid crisis. The company is grappling with major creditors including McKesson Corporation (NYSE:) and Humana (NYSE:) Health. The Justice Department has accused Rite Aid of filling excessive opioid prescriptions, a claim the company denies.

The pharmacy chain has faced stiff competition from larger rivals such as CVS, Walgreens Boots Alliance (NASDAQ:), and Amazon (NASDAQ:), which has led to falling sales and less money available for investment and debt repayment. As of June, Rite Aid had $3.3 billion in debt excluding pending opioid litigation. Its share price has plummeted nearly 81% since the beginning of the year, which aligns with the InvestingPro data showing a year-to-date price total return of -80.59%.

Sarah Foss of Debtwire sees Chapter 11 as the only feasible solution for Rite Aid to navigate this perfect storm of issues. The company has been implementing a downsizing strategy that includes closing stores and planning to shut hundreds more, further eroding its competitive position. This aligns with InvestingPro Tips highlighting that Rite Aid has been quickly burning through cash and its revenue has been declining at an accelerating rate.

Rite Aid’s pharmacy benefit manager, Elixir, which was acquired in 2015 for $2 billion, struggles to compete with industry giants due to its smaller scale. This puts Elixir at a disadvantage when negotiating larger contracts that could generate more cash flow. A failed merger with Walgreens in 2017 resulted in Rite Aid selling over 2,000 stores and three distribution centers to Walgreens for $5.18 billion. Another attempted merger with grocery chain Albertsons (NYSE:) was called off in 2018 due to lack of shareholder support.

During the pandemic, Rite Aid initially saw a sales boost as customers stocked up on sanitizers and beauty products. However, as customers started consolidating their trips to drugstores, Rite Aid’s impulse purchases declined significantly.

Rite Aid was originally established as Thrif D Discount Center in Scranton, Pennsylvania in 1962 before rebranding to Rite Aid in 1968. It underwent rapid expansion across the U.S., becoming the country’s largest drugstore chain at one point. In the late 1990s and early 2000s, Rite Aid was embroiled in a securities and accounting fraud case that forced it to restate earnings by $1.6 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Wall Street eyes Microsoft’s AI bets and cloud growth By Investing.com

Stocks March 26, 2024

Robinhood woos wealthier clients from bigger brokerages- WSJ

Stocks March 25, 2024

Elon Musk says oil and gas should not be demonised

Stocks March 25, 2024

Pro Research: Wall Street dives into Alphabet’s potential and pitfalls

Stocks December 25, 2023

Pro Research: Wall Street eyes on First Solar’s bright future

Stocks December 24, 2023

US court orders new FTC review of Illumina’s Grail deal

Stocks December 23, 2023
Add A Comment

Leave A Reply Cancel Reply

Latest News

TWFG: A Growing Insurance ‘Middle Man’ (NASDAQ:TWFG)

December 10, 2025

Trump’s immigration data dragnet

December 10, 2025

Shinhan Financial: Watch Out For Positive Surprises (NYSE:SHG)

December 9, 2025

Asante Gold: Growth In Medium-Sized Gold Production, But With Relevant Risk

December 8, 2025

The power crunch threatening America’s AI ambitions

December 8, 2025
Trending Now

Macquarie Value Fund Q3 2025 Sales And Purchases

December 7, 2025

Fed expected to cut rates despite deep divisions over US economic outlook

December 7, 2025

Box Q3: Limited Alpha Ahead (NYSE:BOX)

December 5, 2025

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Make a Living is your one-stop news website for the latest personal finance, investing and markets news and updates, follow us now to get the news that matters to you.

We're social. Connect with us:

Facebook Twitter Instagram YouTube LinkedIn
Topics
  • Business
  • Economy
  • Finance
  • Investing
  • Markets
Quick Links
  • Cookie Policy
  • Advertise with us
  • Get in touch
  • Submit News
  • Newsletter

Subscribe to Updates

Get the latest finance, markets, and business news and updates directly to your inbox.

2025 © Make a Living Club. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.